Загрузка...
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)
OBJECTIVE: To evaluate the effect of natalizumab on disability progression beyond 2 years of treatment in clinical practice. METHODS: Analyses included the 496 relapsing-remitting multiple sclerosis (RRMS) patients among 5122 patients in the Tysabri Observational Program (TOP) who had completed 4 co...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714845/ https://ncbi.nlm.nih.gov/pubmed/26771747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144834 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|